Hypoxia-Inducible Factor-1α Activity as a Switch for Glioblastoma Responsiveness to Temozolomide
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hypoxia-Inducible Factor-1α Activity as a Switch for Glioblastoma Responsiveness to Temozolomide
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-07-02
DOI
10.3389/fonc.2018.00249
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MiR-675-5p supports hypoxia induced epithelial to mesenchymal transition in colon cancer cells
- (2017) Viviana Costa et al. Oncotarget
- Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment
- (2016) Jun-Hai Tang et al. EXPERIMENTAL CELL RESEARCH
- Targeting autophagy to sensitive glioma to temozolomide treatment
- (2016) Yuanliang Yan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
- (2016) Caroline Wigerup et al. PHARMACOLOGY & THERAPEUTICS
- MiR675-5p Acts on HIF-1α to Sustain Hypoxic Responses: A New Therapeutic Strategy for Glioma
- (2016) Alessia Lo Dico et al. Theranostics
- Identification of imaging biomarkers for the assessment of tumour response to different treatments in a preclinical glioma model
- (2015) A. Lo Dico et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Lysosomal mTORC2/PHLPP1/Akt Regulate Chaperone-Mediated Autophagy
- (2015) Esperanza Arias et al. MOLECULAR CELL
- p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis
- (2015) WANG MIAO et al. Molecular Medicine Reports
- Silencing of HIF-1α enhances the radiation sensitivity of human glioma growth in vitro and in vivo
- (2015) Zhonghua Luo et al. NEUROPHARMACOLOGY
- Management of BRAF and MEK inhibitor toxicities in patients with metastatic melanoma
- (2015) Sarah J. Welsh et al. Therapeutic Advances in Medical Oncology
- HIF-1α pathway: role, regulation and intervention for cancer therapy
- (2015) Georgina N. Masoud et al. Acta Pharmaceutica Sinica B
- Temozolomide induces autophagy via ATM-AMPK-ULK1 pathways in glioma
- (2014) YUHUI ZOU et al. Molecular Medicine Reports
- Self-consumption: the interplay of autophagy and apoptosis
- (2014) Guillermo Mariño et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Prognostic and Predictive Biomarkers in Adult and Pediatric Gliomas: Toward Personalized Treatment
- (2014) Harry R. Haynes et al. Frontiers in Oncology
- STUB1/CHIP is required for HIF1A degradation by chaperone-mediated autophagy
- (2013) João Vasco Ferreira et al. Autophagy
- IDH1 and IDH2 Mutations in Gliomas
- (2013) Adam L. Cohen et al. Current Neurology and Neuroscience Reports
- Radiation-induced mitotic cell death and glioblastoma radioresistance: A new regulating pathway controlled by integrin-linked kinase, hypoxia-inducible factor 1alpha and survivin in U87 cells
- (2013) Olivia Lanvin et al. EUROPEAN JOURNAL OF CANCER
- Evaluation of mast cells and hypoxia inducible factor-1 expression in meningiomas of various grades in correlation with peritumoral brain edema
- (2013) Joanna Reszec et al. JOURNAL OF NEURO-ONCOLOGY
- Validation of an Engineered Cell Model for In Vitro and In Vivo HIF-1α Evaluation by Different Imaging Modalities
- (2013) A. Lo Dico et al. MOLECULAR IMAGING AND BIOLOGY
- Survival and Death Strategies in Glioma Cells: Autophagy, Senescence and Apoptosis Triggered by a Single Type of Temozolomide-Induced DNA Damage
- (2013) Anna V. Knizhnik et al. PLoS One
- Mitochondrial Bioenergetics of Metastatic Breast Cancer Cells in Response to Dynamic Changes in Oxygen Tension: Effects of HIF-1α
- (2013) Anne R. Diers et al. PLoS One
- Personalized treatment strategies in glioblastoma: MGMT promoter methylation status
- (2013) Niklas Thon et al. OncoTargets and Therapy
- MGMT promoter hypermethylation and its associations with genetic alterations in a series of 350 brain tumors
- (2012) Marta Mellai et al. JOURNAL OF NEURO-ONCOLOGY
- STAT3 Inhibition Overcomes Temozolomide Resistance in Glioblastoma by Downregulating MGMT Expression
- (2012) Shinji Kohsaka et al. MOLECULAR CANCER THERAPEUTICS
- BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression
- (2012) L Persano et al. Cell Death & Disease
- Incorporation of Prognostic and Predictive Factors Into Glioma Clinical Trials
- (2012) Derek R. Johnson et al. Current Oncology Reports
- Luminal and basal-like breast cancer cells show increased migration induced by hypoxia, mediated by an autocrine mechanism
- (2011) Melanie J Voss et al. BMC CANCER
- Pathway inhibition: emerging molecular targets for treating glioblastoma
- (2011) W. Wick et al. NEURO-ONCOLOGY
- Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
- (2011) C. C.-L. Wong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Temozolomide: Mechanisms of Action, Repair and Resistance
- (2011) Jihong Zhang et al. Current Molecular Pharmacology
- Molecular diagnostics of gliomas: the clinical perspective
- (2010) Ghazaleh Tabatabai et al. ACTA NEUROPATHOLOGICA
- A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2α
- (2010) Sascha Seidel et al. BRAIN
- Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide
- (2010) K A van Nifterik et al. BRITISH JOURNAL OF CANCER
- Knock down of HIF-1α in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres
- (2010) Olga Méndez et al. Molecular Cancer
- Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion
- (2010) A N Santhanam et al. ONCOGENE
- Bcl-2 Regulates HIF-1α Protein Stabilization in Hypoxic Melanoma Cells via the Molecular Chaperone HSP90
- (2010) Daniela Trisciuoglio et al. PLoS One
- HIF-1: a key mediator in hypoxia (Review)
- (2009) J. Adams et al. ACTA PHYSIOLOGICA HUNGARICA
- Role of hypoxia in the hallmarks of human cancer
- (2009) Kai Ruan et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
- (2009) G L Semenza ONCOGENE
- HIF-1α and HIF-2α have divergent roles in colon cancer
- (2008) Takaaki Imamura et al. INTERNATIONAL JOURNAL OF CANCER
- Expression of hypoxia inducible factor-1α in tumors of patients with glioblastoma multiforme and transitional meningioma
- (2008) Mehmet Yasar Kaynar et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started